NIDA Power Session - Psychedelics: Update on the Science

9:00 AM
10:15 AM
National Harbor 10-11


Psychedelic substances are mind-altering drugs that influence physiological, cognitive, and emotional states. These substances include a broad range of specific entities including classic hallucinogens (LSD, psilocybin, mescaline, dimethyltryptamine [DMT], and ayahuasca), dissociative drugs (phencyclidine [PCP, angel dust] and ketamine), and others (MDMA [ecstasy, classified as both a hallucinogen and a stimulant], and ibogaine). Use of these substances to treat a variety of health conditions has received a great deal of attention in recent years. It is also notable that use of these substances has been increasing in recent years among adults primarily, and as the legal status of these agents begins to shift, the potential for greater use and misuse is significant. This session will review the current epidemiology, basic science, and policy developments regarding hallucinogens to better equip coalitions to address an emerging substance use issue in their local communities.

Learning Objectives

At the end of this session participants will be able to:
1. Understand the range of drugs that fall under the psychedelics category.
2. Understand major areas of research using psychedelic compounds as a health treatment.
3. Understand emerging details about how psychedelics affect brain structure and function.


Wilson Compton
Deputy Director
National Institute on Drug Abuse